Global Gene Corp wins 2020 Rodenberry prize in Science
Global Gene Corp (Sumit Jamuar, Chairman and CEO, IITD Alum) a genomics biotech company is among four worldwide projects awarded the million-dollar 2020 Roddenberry Prize, designed to advance the vision of ‘Star Trek’ creator Gene Roddenberry to better humanity.
The Roddenberry Foundation supports organizations working on scientific advancements in health and medicine including vaccines, autoimmune diseases, cancer research, and stem cell therapy. Mumbai based Global Gene Corp is democratizing healthcare through genomics by mapping and organizing the world’s genomic diversity, overcoming the bias that 80% of all existing genomic data come from people of European ancestry. In response to Covid-19, the company has expanded its medical technology platforms, originally developed to enable large scale studies on human health, to include a multilingual contact tracing platform with mobility passports and individual risk evaluation.
Sumit Jamuar, Chairman & CEO of Global Gene Corp said: “At Global Gene Corp, we are truly honored and humbled to receive the Roddenberry Foundation Prize for 2020. Growing up on Star Trek, Gene Roddenberry inspired us with his vision of a future where technology is a force for incredible positive impact on humanity. This recognition of our work to create an equitable and fair world where all of us, irrespective of where we live, can benefit by leapfrogging to the healthcare of the future enabled by genomics, digital health and creating the next generation of therapeutics is a truly remarkable moment in our journey to create lasting transformation.”
